Use access key #2 to skip to page content.
$8.18 0.18 (2.25%)
11/21/2008 4:00 PM

Palomar Medical Technologies, Inc. (PMTI)

CAPS Rating:
****

The Company is a researcher and developer of innovative aesthetic light based systems for hair removal and other cosmetic procedures.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating PMTI

Add Stock to Watchlist

What the Community Thinks

Total Members

576 Outperforms
33 Underperforms
 

All-Stars

124 Outperforms
6 Underperforms
 

Wall Street

5 Outperforms
1 Underperforms
 

Members bullish on PMTI are also bullish on:

Members bearish on PMTI are also bearish on:

Ticker Tags

Healthcare Equipment and Supplies (183), Equipment (55), Micro Cap (5043), Medical Lasers (5)
Suggest a tag

Palomar Medical Technologies, Inc. At A Glance

Current Price: $8.18
Last Trade Time: 11/21/2008 4:00 PM
Open: $8.10
Previous Close: $8.00
Daily Range: $7.43 - $8.40
52-Week Range: $7.95 - $21.10
Volume: 257,961
Market Cap: $145.18M
P/E Ratio: 38.10
Compare Our Special Broker Offers!

Stock Trends

PMTI VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

5

Palomar Medical Technologies, Inc. (PMTI)

Avatar Calgary411 (< 20) Submitted: 2/24/08 11:55 AM

This bullet proof distribution partnership is a shareholders dream!
I personally bought Palomar Medical Technologies shares because of their smart vision to ink an exclusive distribution agreement with Q-MED. (excluding North America)
Q-MED AB is the producer of Restylane. Restylane is the expensive...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

3

Palomar Medical Technologies, Inc. (PMTI)

Avatar OOji (99.92) Submitted: 5/17/08 4:25 PM

One dollar per share is the ultimate target.

Replies: 2 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 104 :   1 2 3 4 5 Next » Jump to page:

Show Pitch Replies

Recs

0

 (PMTI)

Avatar DocPhoton (< 20) Submitted: 7/07/08 2:06 PM : Outperform Start Price: $9.85 PMTI Score: 21.84

optics

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PMTI)

Avatar johnedwardkang (< 20) Submitted: 5/29/08 2:19 PM : Outperform Start Price: $11.00 PMTI Score: 20.47

I see this going back to 36

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PMTI)

Avatar Chemdawg (< 20) Submitted: 5/23/08 12:03 AM : Outperform Start Price: $11.54 PMTI Score: 16.32

vanity is one of the primary drives that make us who we are.sex sells and anything that increases the chances has to be a priority even in an economic downturn.If I have noticed anything about how we behave it is that we aren't changing our daily lives no matter how expensive it is. even with $4 gas looming I still see plenty of SUVs in driveways. people just aren't that smart.on the technical side this stock has taken a beating and it has no debt and a book value of 8/per share. We are sitting 12% over a 52 week low and I can't really understand why. My gut tells me we are headed for a bounce here pretty soon.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (PMTI)

Avatar Wannabeda1 (< 20) Submitted: 5/17/08 2:43 PM : Outperform Start Price: $11.30 PMTI Score: 19.29

No debt, $7.91 per share in working capital, 6 year average eps is 0.9, book value has steady growth in each of the last 6 years. Most of all this is company is growing its international exposure, in two years should make up %50 of sales. This company is partnered up with JNJ and PG - may also make a buyout target at the current bargain valuation.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

 (PMTI)

Avatar Sebtor (63.91) Submitted: 5/14/08 12:16 PM : Outperform Start Price: $11.32 PMTI Score: 18.74

The stock trades at about 1,3 times book and 15,7 times last earnings. Interesting... even more interesting is the fact that Palomar has no long term debt and cash reserves of more than 4,30 bucks per share (after all liabilities are discounted). Even with the disgusting earnings of 1Q/2008 this means a trailing PE of just 10.


I could continue by talking about Palomars long term growth but instead I'd like to point out, that a Palomar director bought shares of his company worth more than 100.000 $ on the 6th of May.

Report this Post Replies: 1 | Reply | Permalink

Results 1 - 5 of 104 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 6 of 6  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackStanfordRes 48.20 09/19/08 Outperform NS $15.20-46.18%-40.41%-5.78
TrackJGreenblatt 23.02 04/11/08 Outperform 1Y $14.53-43.70%-43.45%-0.25 Toggle the visibility of 60-Second Pitch and replies
TrackJimCramer 85.65 04/23/07 Underperform 3W $37.94-78.44%-48.78%+29.66
TrackMatrix 90.83 04/10/07 Outperform NS $40.28-79.69%-47.46%-32.23
TrackWRHambrecht < 20 02/28/07 Outperform NS $41.06-80.08%-45.98%-34.09
TrackNeedham < 20 10/27/06 Outperform NS $46.95-82.58%-45.28%-37.30

Results 1 - 6 of 6  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

Sponsored Links